Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms
Metrics: PDF 980 views | HTML 1402 views | ?
Carolina Oliveira Rodini1, Patrícia Benites Gonçalves da Silva1, Amanda Faria Assoni1,2, Valdemir Melechco Carvalho2 and Oswaldo Keith Okamoto1,3
1Centro de Pesquisa sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, Cidade Universitária, São Paulo, SP, Brazil
2Fleury Group, São Paulo, Jabaquara, São Paulo, SP, Brazil
3Departamento de Hemoterapia e Terapia Celular, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
Oswaldo Keith Okamoto, email: email@example.com
Keywords: glioblastoma; tumor microenvironment; mesenchymal stem cells; aggressiveness; secretome
Received: November 03, 2017 Accepted: April 23, 2018 Published: May 15, 2018
Mesenchymal stem cells (MSC) display tumor tropism and have been addressed as vehicles for delivery of anti-cancer agents. As cellular components of the tumor microenvironment, MSC also influence tumor progression. However, the contribution of MSC in brain cancer is not well understood since either oncogenic or tumor suppressor effects have been reported for these cells. Here, MSC were found capable of stimulating human Glioblastoma (GBM) cell proliferation through a paracrine effect mediated by TGFB1. Moreover, when in direct cell-cell contact with GBM cells, MSC elicited an increased proliferative and invasive tumor cell behavior under 3D conditions, as well as accelerated tumor development in nude mice, independently of paracrine TGFB1. A secretome profiling of MSC-GBM co-cultures identified 126 differentially expressed proteins and 10 proteins exclusively detected under direct cell-cell contact conditions. Most of these proteins are exosome cargos and are involved in cell motility and tissue development. These results indicate a dynamic interaction between MSC and GBM cells, favoring aggressive tumor cell traits through alternative and independent mechanisms. Overall, these findings indicate that MSC may exert pro-tumorigenic effects when in close contact with tumor cells, which must be carefully considered when employing MSC in targeted cell therapy protocols against cancer.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.